Inhibition of the TNF-α/nuclear factor-kappaB (NF-κB)/TGF-β signaling pathway can effectively suppress myocardial fibrosis and cardiac remodeling, thereby attenuating the progression of AF (63). This evidence concerns the gene TNF and atrial fibrillation.